Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/138.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Binds expression product or fragment thereof of cancer-related gene (e.g., oncogene, proto-oncogene, etc.)
Description: Subject matter involving an antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an expression product or fragment thereof of a cancer-related gene, such as an oncogene or a proto-oncogene.










Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12

Patent Number Title Of Patent Date Issued
8709418 Pharmaceutical composition for treating CAPRIN-1 expressing cancer Apr. 29, 2014
8709421 Combination of the application of antibodies for immunostimulation together with glucocorticoids Apr. 29, 2014
8710194 Single-chain variable fragment (scFv) able to recognize and bind CD99 human protein Apr. 29, 2014
8703143 Antibodies of the ED-B domain of fibronectin, their construction and uses Apr. 22, 2014
8703920 Fully human antibodies against N-cadherin Apr. 22, 2014
8691232 Extending time to disease progression or survival in cancer patients Apr. 8, 2014
8691229 Method of PLSCR inhibition for cancer therapy Apr. 8, 2014
8685399 PAX 5 monoclonal antibody Apr. 1, 2014
8673303 Cripto blocking antibodies and uses thereof Mar. 18, 2014
8658168 Compositions and methods for homoconjugates of antibodies which induce growth arrest of apoptosis of tumor cells Feb. 25, 2014
8658175 Anti-EGFR antibodies and their uses Feb. 25, 2014
8652474 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof Feb. 18, 2014
8652472 Compositions and methods for diagnosing and treating cancer Feb. 18, 2014
8652466 Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for Fc.gamma.R.sub.activating and Fc.gamma.R.sub.inhibiting Feb. 18, 2014
8647623 Method for treatment of blood tumor using anti-TIM-3 antibody Feb. 11, 2014
8642036 Treatment with anti-ErbB2 antibodies Feb. 4, 2014
8642032 Method for screening of patient to be administered with pharmaceutical agent comprising anti-cancer antibody as active ingredient Feb. 4, 2014
8637012 Genetic products differentially expressed in tumors and the use thereof Jan. 28, 2014
8637026 Anti-C35 antibody combination therapies and methods Jan. 28, 2014
8637027 Anti c-Met antibodies Jan. 28, 2014
8628774 Compositions and methods for treating and diagnosing cancer Jan. 14, 2014
8623356 Demibodies: dimerization-activated therapeutic agents Jan. 7, 2014
8613907 Compositions that inhibit proliferation of cancer cells Dec. 24, 2013
8609095 Anti-HER2 antibodies and compositions Dec. 17, 2013
8609096 Monoclonal antibodies against PCBP-1 antigens, and uses therefor Dec. 17, 2013
8603479 Class I anti-CEA antibodies and uses thereof Dec. 10, 2013
8603477 Use of anti-CS1 antibodies for treatment of rare lymphomas Dec. 10, 2013
8603465 Methods for treatment of polyposis Dec. 10, 2013
8603466 Agonist antibodies against TSHR Dec. 10, 2013
8591889 Human monoclonal antibodies specific for CD22 Nov. 26, 2013
8591893 Paratope and epitope of anti-mortalin antibody Nov. 26, 2013
8591897 Anti-ERBB2 antibody adjuvant therapy Nov. 26, 2013
8591903 Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation Nov. 26, 2013
8591943 Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors Nov. 26, 2013
8568718 Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same Oct. 29, 2013
8557244 Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody Oct. 15, 2013
8545845 Antibodies against domains of laminin-332 Oct. 1, 2013
8540989 Compositions and methods for treating and diagnosing cancer Sep. 24, 2013
8540991 Monoclonal antibodies against PCBP-1 antigens, and uses therefor Sep. 24, 2013
8535670 Method of treating colorectal cancer tumor Sep. 17, 2013
8535676 Antibody therapy Sep. 17, 2013
8529901 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label Sep. 10, 2013
8529900 Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer Sep. 10, 2013
8529891 Inhibitors of extracellular HSP90 Sep. 10, 2013
8524672 Method for inhibiting BAFF-R activity Sep. 3, 2013
8524867 Optimized antibodies that target CD19 Sep. 3, 2013
8518403 Expression-enhanced polypeptides Aug. 27, 2013
8518405 Tumor specific antibodies and uses therefor Aug. 27, 2013
8513199 Methods for treating conditions associated with c-fms Aug. 20, 2013
8513028 Use of MLN51 gene and protein Aug. 20, 2013

1 2 3 4 5 6 7 8 9 10 11 12










 
 
  Recently Added Patents
Coated article and method for making the same
Systems and methods for dynamically modifying subcriber service profile stored in home location register while roaming in wireless telecommunication networks
Enediyne compounds, conjugates thereof, and uses and methods therefor
Estimating travel time
Die packages and systems having the die packages
Method of sheet alignment and method of post-processing comprising the same and method of image formation
LED light
  Randomly Featured Patents
Olefin process with removal of aromatic by-products
Ultraviolet-curable resin material for pattern transfer and magnetic recording medium manufacturing method using the same
Image capturing device having de-friction function
Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
Prefabricated corner bead
Chair
Optical fibers having a fluoride glass cladding and method of making
Pant cuff protecting device and method
Secondary latch and indicator for fluid coupling
Coupling element for a hearing aid